Autres langues Ainos, Inc.

Actions

AIMD

US00902F4028

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 19/08/2026			Varia. 5j.	Varia. 1 janv.
1,480 ^USD	+5,71%		-0,67%	-9,76%

03/08	Ainos, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
27/05	Les plus fortes baisses de l'avant-bourse	MT

Autres langues

19/08	Ainos Launches Atmosphere Engine, Extending Physical AI from Environmental Sensing to Active Environmental Management
17/08	Ainos Unveils Next-Generation AI Nose, Advancing the Infrastructure for Chemical Intelligence
13/08	Ainos Surpasses 878 Million Real-World Data Points, Up 43% in 23 Days as 1,400-System AI Nose Semiconductor Deployment Advances
12/08	Ainos to Showcase Environmental Intelligence for Physical AI at SEMICON Taiwan 2026
10/08	VASRO Research Highlights Ainos' Progress in Scaling Smell AI Commercialization and Compounding Its Smell ID Dataset
06/08	Zacks Small-Cap Research Covers Ainos' AI Nose Platform and Expansion of Smell AI Applications
03/08	Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets
03/08	Ainos, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
21/07	Ainos Expands Smell AI With Growing Real-World Scent Dataset for Physical AI
22/06	VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence
17/06	RedChip's Future Tech Investor Conference Replays Now Available
17/06	Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program
08/06	Ainos Releases 2026 Mid-Year CEO Letter to Shareholders
05/06	VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations
04/06	RedChip Showcases Public Companies Driving Technological Innovation at June 10 Virtual Investor Conference
03/06	Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study
01/06	Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis
27/05	Top Premarket Decliners
20/05	VASRO Research Highlights Ainos AI Nose Commercialization Progress and Semiconductor Industry Shift Toward AI-Driven Environmental Intelligence
18/05	Zacks Small-Cap Research Highlights Ainos' Smell AI Commercialization
13/05	Ainos, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
13/05	Ainos Reports First Quarter 2026 Financial Results and Highlights Smell AI Execution Across Semiconductors and Healthcare Infrastructure Markets
11/05	Ainos Updates Standard Industrial Classification Code to Reflect Smell AI Business Focus
17/04	VASRO: Ainos Expands Smell AI from Industrials into Healthcare Infrastructure, Reinforcing AI Infrastructure Positioning and Multi-Vertical Scalability
08/04	Ainos, MacKay Memorial Hospital and Topco Scientific Partner to Advance Smell AI Deployment in High-Risk Hospital Environments